Home News

Company News

Certification
Good quality Automatic Labeling Machine for sales
Good quality Automatic Labeling Machine for sales
Customer Reviews
The Fluid Bed Dryer is really strong machine, bro!

—— Bob, California, USA

We are so glad to know you and be your partner. Welcome to Philippines

—— Edgar, Davao, Philippines

Conductivity of Purified Water after your double RO machine is 0.54 since our raw water is 428. Thanks, my friend.

—— Habibur, Dhaka, Bangladesh

su empresa es un genio de maquinaria! Glad to be your partner in Peru.

—— Diaz, Lima, Peru

I'm Online Chat Now
Company News
china latest news about CPhI China opens with analysis pointing to a surge in growth in 2019

CPhI China opens with analysis pointing to a surge in growth in 2019

[2019-06-11 13:49:29]
New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organised by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation. The ... Read More
china latest news about Biogen completes Nightstar acquisition

Biogen completes Nightstar acquisition

[2019-06-10 17:11:43]
Biogen has announced that it has completed its acquisition of Sycona’s Nightstar Therapeutics, the clinical-stage gene therapy company, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders. The companies announced the acquisition in March this year, with the ... Read More
china latest news about Just 44% of UK health sector would trust humans over AI

Just 44% of UK health sector would trust humans over AI

[2019-06-10 17:10:31]
New online research from YouGov into the use of artificial intelligence (AI) in the workplace has revealed that only one in ten office workers surveyed in the health sector believe AI will reduce the number of people in their team - the lowest count of any industry surveyed. The research surveyed 2... Read More
china latest news about Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

[2019-06-10 16:28:28]
DIT: added information about US subsidiary presentation on Alzheimer’s pipeline Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated. BAN2401 is being ... Read More
china latest news about AstraZeneca's Bydureon gets a facelift, but can it stand out in a GLP-1 market that's only getting tougher?

AstraZeneca's Bydureon gets a facelift, but can it stand out in a GLP-1 market that's only getting tougher?

[2017-10-25 16:46:56]
AstraZeneca’s Bydureon took a blow back in May when it failed to cut down cardiovascular risks in Type 2 diabetes patients. But the company is hoping a new formulation will give the medication some competitive firepower. The British drugmaker has scored an approval for Bydureon BCise, which has ... Read More
china latest news about Novartis edges Roche in targeted melanoma with Tafinlar-Mekinist adjuvant 'breakthrough'

Novartis edges Roche in targeted melanoma with Tafinlar-Mekinist adjuvant 'breakthrough'

[2017-10-25 16:46:14]
Score one for Novartis in its quest to expand its cancer-fighting combo, Tafinlar and Mekinist. Monday, the FDA bestowed its “breakthrough” tag on the pair in adjuvant, BRAF V600 mutation-positive melanoma, setting it up for a quick trip down the regulatory path to approval. The agency’s decision to ... Read More
china latest news about GlaxoSmithKline picks up NICE recommendation for Strimvelis, a €594,000 gene therapy

GlaxoSmithKline picks up NICE recommendation for Strimvelis, a €594,000 gene therapy

[2017-10-25 16:44:09]
Despite being one of the most expensive drugs in the world, GlaxoSmithKline's gene therapy Strimvelis won the backing of the often stingy U.K. cost watchdogs to treat a rare disease called ADA-SCID, or "bubble boy" syndrome. The drug, which costs €594,000 (about $700,000), is a one-time treatment ... Read More
china latest news about Lilly weighs spinoff of bulked up Elanco even as it beats Street estimates in Q3

Lilly weighs spinoff of bulked up Elanco even as it beats Street estimates in Q3

[2017-10-25 16:41:55]
Already working to slim down with thousands of job cuts, Eli Lilly announced on Tuesday it's looking at options for animal health business Elanco that could include a sale. At the same time, the drugmaker reported Street-beating sales for the third quarter, prompting it to boost its guidance for the ... Read More
china latest news about Akorn sterile plant in Illinois smacked again by the FDA

Akorn sterile plant in Illinois smacked again by the FDA

[2017-10-25 16:06:55]
An Akorn sterile injectables plant in Illinois is in hot water with the FDA again, but this time it may be a problem for Fresenius Kabi, which is buying the generics manufacturer in a $4.3 billion deal. According to a recently posted FDA Form 483, the agency found new issues with Akorn’s sterile ... Read More
china latest news about Mylan blasts Allergan's 'desperate' tribal licensing deal on Restasis

Mylan blasts Allergan's 'desperate' tribal licensing deal on Restasis

[2017-09-15 15:09:04]
Mylan has had no shortage of critics over the last year as it suffered from a stinging EpiPen pricing scandal. Now, the generic giant is dishing out barbs of its own, blasting Allergan for a new licensing deal with the Saint Regis Mohawk Tribe that’s designed to shield eye drug Restasis from ... Read More
Page 1 of 6|< 1 2 3 4 5 6 >|